Clinical trial
Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study
NCT06868953 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study
- Lead sponsor
- IRCCS San Raffaele Roma
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 10, 2025
- Completion date
- December 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
migraine